AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Gerresheimer AG
Video analysis: GRRMF
All videosNo video analysis for this stock yet. Request one from our team.
News: GRRMF
Gerresheimer AG (GRRMY) Q1 2026 Earnings Call Transcript
Gerresheimer AG (GRRMY) Q1 2026 Earnings Call Transcript
Gerresheimer Q1 Earnings Call Highlights
Gerresheimer ETR: GXI reported preliminary first-quarter 2026 results that showed modest revenue growth but lower earnings as the packaging and drug-delivery company prioritized cash preservation, reduced capital spending and limited inventory buildup.
Germany's Gerresheimer to sell two units to Apax for $1.71 billion including debt
German drugs packaging firm Gerresheimer said on Wednesday it was selling two of its packaging units to private equity group Apax Funds for €1.5 billion ($1.71 billion) including debt.
Gerresheimer Q4 Earnings Call Highlights
Gerresheimer ETR: GXI said it has completed a broad review of compliance and accounting matters, published its audited 2025 annual report and is now focused on selling Centor, refinancing debt and improving cash generation.